AstraZeneca PLC

Drug and utility shares drive FTSE 100 into the green

9:26 a.m. July 10, 2020

- Barbara Kollmeyer

Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed

2:06 p.m. June 29, 2020

- Jaimy Lee

European stocks inch higher after previous day’s pounding; Wirecard collapses

5:57 a.m. June 25, 2020

- Steve Goldstein

European stocks in the red as investors fret about rising U.S. Covid-19 infections

4:53 a.m. June 24, 2020

- Barbara Kollmeyer

Here’s how U.K. fund managers are investing, based on where they think inflation will go

8:41 a.m. June 16, 2020

- Lina Saigol

Germany investing in coronavirus vaccine maker that it accused the Trump administration of trying to poach

11:37 a.m. June 15, 2020

- Barbara Kollmeyer

FTSE 100 slumps on worries over virus and BP’s lowered oil-price outlook

5:59 a.m. June 15, 2020

- Steve Goldstein

Gilead's stock rallies and AstraZeneca falls, after reports of preliminary merger interest, which have been dropped

7:02 a.m. June 8, 2020

- Tomi Kilgore

London Stock Exchange is worst-performing U.K. blue chip as trading hour debate heats up

6:36 a.m. June 8, 2020

- Steve Goldstein

Stocks in Europe edge lower after strong rally

5:41 a.m. June 8, 2020

- Steve Goldstein

AstraZeneca starts manufacturing potential Oxford University vaccine and strikes deal with Bill Gates-backed health organizations

11:03 a.m. June 5, 2020

- Callum Keown

European stocks fall on rising U.S.-China tensions

6:06 a.m. May 29, 2020

- Barbara Kollmeyer

Everything you need to know about the Oxford University vaccine and other efforts to beat coronavirus

7:29 a.m. May 22, 2020

- Callum Keown

U.S. gives AstraZeneca $1.2 billion to fund Oxford University coronavirus vaccine — America would get 300 million doses beginning in October

7:00 a.m. May 22, 2020

- Callum Keown

U.S. to invest $1.2 billion to secure potential coronavirus vaccine from AstraZeneca, Oxford University

8:31 a.m. May 21, 2020

- Denise Roland

AstraZeneca says it can produce 1 billion doses of Oxford's potential COVID-19 vaccine

2:07 a.m. May 21, 2020

- Steve Goldstein

AstraZeneca made a bet on Moderna back in 2013. Here’s what it’s worth now

12:30 p.m. May 20, 2020

- Lina Saigol

European stocks slip amid coronavirus vaccine doubts

9:04 a.m. May 20, 2020

- Barbara Kollmeyer

Three dividend stocks of cash-flow-rich companies poised to thrive during this economic crisis

12:36 p.m. May 9, 2020

- Philip van Doorn

Pound slumps after construction sector sees worst decline on record

11:11 a.m. May 6, 2020

- Barbara Kollmeyer

Roche’s Immunotherapy Drug Extended Patients’ Lives

10:20 p.m. Dec. 7, 2017

- The Wall Street Journal Interactive Edition

In U.K., Barriers Rising Against Foreign Deals

10:28 a.m. May 11, 2015

- The Wall Street Journal Interactive Edition

Celgene Profit Surges, Driven by Revlimid Sales

8:18 a.m. April 30, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca Reports Fall in First-Quarter Profit

8:26 a.m. April 24, 2015

- The Wall Street Journal Interactive Edition

Billion-Dollar Health Startups

5:21 p.m. Feb. 27, 2015

- The Wall Street Journal Interactive Edition

Valeant to Buy Salix for About $10 Billion

9:44 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

New Cancer Technology Cheers Investors

4:35 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

Valeant Nears Deal to Buy Salix

2:58 p.m. Feb. 22, 2015

- The Wall Street Journal Interactive Edition

Actavis Changing Name to Allergan

12:24 p.m. Feb. 18, 2015

- The Wall Street Journal Interactive Edition

Pharma Must Launch Itself Back

8:17 p.m. Feb. 16, 2015

- The Wall Street Journal Interactive Edition

Corporate Watch: News Digest

12:42 a.m. Feb. 6, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca Deals Up a Tricky 2015

12:55 p.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

Pfizer to Buy Hospira for $16 Billion

11:22 a.m. Feb. 6, 2015

- The Wall Street Journal Interactive Edition

Astra to Buy Actavis Portfolio

7:54 a.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

New Outsourcing Frontier in India: Monitoring Drug Safety

11:20 p.m. Feb. 2, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca to Harness Benefits of Genome-Editing Technology

7:06 a.m. Jan. 29, 2015

- The Wall Street Journal Interactive Edition

Pfizer Sales Hit by Stronger Dollar

10:53 p.m. Jan. 27, 2015

- The Wall Street Journal Interactive Edition

Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug

6:07 p.m. Jan. 26, 2015

- The Wall Street Journal Interactive Edition

Peter Wallenberg Dies at 88

4:26 p.m. Jan. 19, 2015

- The Wall Street Journal Interactive Edition

Pharma Grows Itself a New Challenge -- Overheard

7:51 p.m. Jan. 13, 2015

- The Wall Street Journal Interactive Edition